Vascular APIs

Each prostaglandin (PG) evokes distinct physiological effects through specific cell surface receptors. PGI₂ (prostacyclin) promotes smooth muscle relaxation and inhibits platelet activation through the IP receptor. Agonists of IP, including epoprostenol, iloprost, and treprostinil, are effective in relaxing pulmonary arterial smooth muscle and are used in the treatment of pulmonary hypertension.

Contact Expert

Regulatory Compliance

US FDA and EMA compliant

Scientific Precision

Analytical standards of impurities and degradation products available

Vascular

Advanced prostaglandin analogues for vascular and pulmonary therapy.

Epoprostenol sodium salt molecular structure

CGMP Epoprostenol sodium salt

CAS: 61849-14-7

GMP material is available, and the DMF is on file with the US FDA, Canada, Japan, Australia, and many EU member states.

Vascular pharmaceutical research

Expert Registration Support

Connect with our registration specialists to review detailed DMF filings, stability data, or to arrange technical documentation transfers.

Contact Expert